Drew Adams
Impact in
- Pharmacology top 5%
- Piperaceae Chemical and Biological Studies
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Protein Degradation and Inhibitors 10
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 5
- Nuclear Structure and Function 3
- Histone Deacetylase Inhibitors Research 3
- Sphingolipid Metabolism and Signaling 3
-
- MicroRNA in disease regulation 5
- Cancer Genomics and Diagnostics 4
- Co-authors
- Stuart L. Schreiber (8 shared papers)Alykhan F. Shamji (4 shared papers)Bridget K. Wagner (3 shared papers)Andrew M. Stern (2 shared papers)Mingji Dai (2 shared papers)David A. Evans (2 shared papers)Dharmaraja Allimuthu (6 shared papers)Mohamed E. Abazeed (8 shared papers)
- Journals
- ACS Chemical Biology (7 papers)Nature Communications (5 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)Cell chemical biology (3 papers)Journal of the American Chemical Society (2 papers)
- Partner nations
- United StatesJapanTaiwan
In The Last Decade
Drew Adams
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Pharmacology 163
- Cancer Research 174
- Developmental Neuroscience 46
- Molecular Biology 706
- Biochemistry 70
Countries citing papers authored by Drew Adams
This map shows the geographic impact of Drew Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew Adams more than expected).
Fields of papers citing papers by Drew Adams
This network shows the impact of papers produced by Drew Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew Adams. The network helps show where Drew Adams may publish in the future.
Co-authors
The 25 scholars most cited alongside Drew Adams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 198 | |
| 2 | 2012 | 142 | |
| 3 | 2016 | 114 | |
| 4 | 2013 | 90 | |
| 5 | 2022 | 58 | |
| 6 | 2013 | 55 | |
| 7 | 2007 | 43 | |
| 8 | 2017 | 35 | |
| 9 | 2019 | 34 | |
| 10 | 2021 | 32 | |
| 11 | 2019 | 29 | |
| 12 | 2012 | 28 | |
| 13 | 2018 | 27 | |
| 14 | 2022 | 23 | |
| 15 | 2021 | 23 | |
| 16 | 2015 | 23 | |
| 17 | 2013 | 22 | |
| 18 | 2018 | 19 | |
| 19 | 2019 | 15 | |
| 20 | 2022 | 12 |
About Drew Adams
Drew Adams is a scholar working on Molecular Biology, Cancer Research, Oncology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (10 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (5 papers), Ubiquitin and proteasome pathways (5 papers), Cancer Genomics and Diagnostics (4 papers), Nuclear Structure and Function (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Sphingolipid Metabolism and Signaling (3 papers). The work is most often cited by research in Pharmacology (163 citations), Cancer Research (174 citations), Developmental Neuroscience (46 citations), Molecular Biology (706 citations) and Biochemistry (70 citations). Drew Adams has collaborated with scholars based in United States, Japan and Taiwan. Frequent co-authors include Stuart L. Schreiber, Alykhan F. Shamji, Bridget K. Wagner, Andrew M. Stern, Mingji Dai, David A. Evans, Dharmaraja Allimuthu, Mohamed E. Abazeed, Yuan Yuan and Joshiawa Paulk. Their work appears in journals such as ACS Chemical Biology, Nature Communications, International Journal of Radiation Oncology*Biology*Physics, Cell chemical biology and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.